ANTIENDOTOXIN MONOCLONAL-ANTIBODIES FOR GRAM-NEGATIVE SEPSIS - GUIDELINES FROM THE IDSA

被引：26

作者：

WENZEL, RP

ANDRIOLE, VT

BARTLETT, JG

BATT, MD

BULLOCK, WE

COBBS, CG

LIGHT, B

MARTIN, MA

SANFORD, J

SANDE, MA

机构：

[1] YALE UNIV,SCH MED,DEPT MED,333 CEDAR ST,201 LCI,NEW HAVEN,CT 06510

[2] VET AFFAIRS MED CTR,BIRMINGHAM,AL

[3] OREGON HLTH SCI UNIV,PORTLAND,OR 97201

[4] UNIFORMED SERV UNIV HLTH SCI,BETHESDA,MD 20814

[5] LUTHERAN GEN HOSP,DIV HOSP EPIDEMIOL,PK RIDGE,IL 60068

[6] JOHNS HOPKINS UNIV HOSP,DIV INFECT DIS,BALTIMORE,MD 21205

[7] UNIV CINCINNATI,MED CTR,DIV INFECT DIS,CINCINNATI,OH 45267

[8] SAN FRANCISCO GEN HOSP,SAN FRANCISCO,CA 94110

[9] UNIV IOWA,COLL MED,DEPT INTERNAL MED,DIV GEN MED CLIN EPIDEMIOL & HLTH SERV RES,IOWA CITY,IA 52242

[10] ST BONIFACE GEN HOSP,WINNIPEG R2H 2A6,MANITOBA,CANADA

来源：

CLINICAL INFECTIOUS DISEASES | 1992年 / 14卷 / 04期

关键词：

D O I：

10.1093/clinids/14.4.973

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：973 / 976

页数：4

共 50 条

[1] ANTIENDOTOXIN MONOCLONAL-ANTIBODIES FOR GRAM-NEGATIVE SEPSIS
CHMEL, H
EMMANUEL, G
CLINICAL INFECTIOUS DISEASES, 1992, 15 (02) : 371 - 371
[2] GRAM-NEGATIVE SEPSIS, THE SEPSIS SYNDROME, AND THE ROLE OF ANTIENDOTOXIN MONOCLONAL-ANTIBODIES
BARRIERE, SL
GUGLIELMO, BJ
CLINICAL PHARMACY, 1992, 11 (03): : 223 - 235
[3] COST EFFICACY ANALYSIS OF TREATMENT WITH ANTIENDOTOXIN MONOCLONAL-ANTIBODIES IN SEPSIS BY GRAM-NEGATIVE BACILLI
BADIA, X
SEGU, L
ALONSO, FG
ROVIRA, J
MEDICINA CLINICA, 1993, 100 (03): : 84 - 89
[4] ADOPTIVE IMMUNOTHERAPY OF GRAM-NEGATIVE SEPSIS - USE OF MONOCLONAL-ANTIBODIES TO LIPOPOLYSACCHARIDE
FINK, MP
CRITICAL CARE MEDICINE, 1993, 21 (02) : S32 - S39
[5] MONOCLONAL-ANTIBODIES AND SEPSIS BY GRAM-NEGATIVE GERMS - IS THEIR USE REALLY JUSTIFIED
BADIA, X
SEGU, L
ALONSO, FG
ROVIRA, J
MEDICINA CLINICA, 1993, 101 (07): : 278 - 278
[6] MONOCLONAL ANTIENDOTOXIN ANTIBODIES FOR THE TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SEPTIC SHOCK
BAUMGARTNER, JD
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (10) : 711 - 716
[7] GRAM-NEGATIVE SEPSIS - PATHOPHYSIOLOGY OF INFECTION, DEVELOPMENT OF POLYCLONAL, MONOCLONAL HUMAN HYBRID AND MURINE ANTIENDOTOXIN ANTIBODIES
QUINTILIANI, R
COOPER, B
MADERAZO, E
NIGHTINGALE, C
HOSPITAL FORMULARY, 1991, 26 (12): : 960 - &
[8] COST-EFFECTIVENESS OF MONOCLONAL-ANTIBODIES TO GRAM-NEGATIVE ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS IN ICU PATIENTS
CHALFIN, DB
HOLBEIN, MEB
FEIN, AM
CARLON, GC
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02): : 249 - 254
[9] MONOCLONAL-ANTIBODIES FOR TREATMENT OF GRAM-NEGATIVE INFECTIONS
YOUNG, LS
GASCON, R
ALAM, S
BERMUDEZ, LEM
REVIEWS OF INFECTIOUS DISEASES, VOL 11, SUPPL 7: CONTROVERSIES IN THE MANAGEMENT OF INFECTIOUS COMPLICATIONS OF NEOPLASTIC DISEASES, 1989, : S1564 - S1571
[10] MONOCLONAL-ANTIBODIES PROTECT AGAINST LETHAL EFFECTS OF GRAM-NEGATIVE BACTERIAL SEPSIS
DUNN, DL
MACH, PA
CERRA, FB
SURGICAL FORUM, 1983, 34 : 142 - 144

← 1 2 3 4 5 →